Cost–effectiveness of vaccinating adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Germany
about
Cost-effectiveness of pneumococcal vaccination strategies for the elderly in KoreaCost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+ Years in Spain.Economic Evidence of Pneumococcal Vaccination in Older Adults: Uncertain Modelling or Competitive Tendering?Evaluating the costs and benefits of pneumococcal vaccination in adults.Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany.Cost-effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK.A public health and budget impact analysis of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK.The full benefits of adult pneumococcal vaccination: A systematic review.Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany.
P2860
Q33675229-83149EAD-48CC-4D3D-B906-FE0E8A6F7F06Q36446832-B9F2B04B-09AE-4DD7-8DE7-410C5C2F0B98Q38620718-91473DA5-BC95-4921-8BC4-FBB0B7CB7364Q38966828-C85F6CBC-CB6B-4BE5-A03F-D7C7787D8574Q39976528-BFCA5B51-4C81-4AD8-8C03-40D6F17368FFQ41753512-449F6CE8-E07F-4B8B-9F14-0D20886FBC22Q41755202-48D0CD3C-2803-45EA-8482-E68396B37806Q47098784-BD36CFAA-7915-4A78-80DF-9EF1963B18CBQ55277513-0AF94798-32A1-444D-B931-B57F2CFFB9E1
P2860
Cost–effectiveness of vaccinating adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Germany
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2012
@uk
name
Cost–effectiveness of vaccinat ...... ide vaccine (PPV23) in Germany
@en
Cost–effectiveness of vaccinat ...... ococcal polysaccharide vaccine
@nl
type
label
Cost–effectiveness of vaccinat ...... ide vaccine (PPV23) in Germany
@en
Cost–effectiveness of vaccinat ...... ococcal polysaccharide vaccine
@nl
prefLabel
Cost–effectiveness of vaccinat ...... ide vaccine (PPV23) in Germany
@en
Cost–effectiveness of vaccinat ...... ococcal polysaccharide vaccine
@nl
P2093
P2860
P356
P1476
Cost–effectiveness of vaccinat ...... ide vaccine (PPV23) in Germany
@en
P2093
Aline Gauthier
Laurence Nicolas-Spony
Lieven Annemans
Mark van der Linden
Xavier Bresse
Yiling Jiang
P2860
P304
P356
10.1586/ERP.12.54
P577
2012-10-01T00:00:00Z